GlyTech, Inc. Enters Collaboration with OBI Pharma (Taiwan)

We are pleased to announce that we have signed a Marketing Agreement and a Materials Transfer Agreement with OBI Pharma, Inc. (Head office: Taipei, Taiwan; CEO: Dr. Heidi Wang) with the aims of reaching potential customers in Japan and advancing glycan production.